C. Cazorla

413 total citations
9 papers, 278 citations indexed

About

C. Cazorla is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, C. Cazorla has authored 9 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Public Health, Environmental and Occupational Health and 4 papers in Parasitology. Recurrent topics in C. Cazorla's work include Viral Infections and Vectors (3 papers), Hepatitis C virus research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). C. Cazorla is often cited by papers focused on Viral Infections and Vectors (3 papers), Hepatitis C virus research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). C. Cazorla collaborates with scholars based in France, Switzerland and Norway. C. Cazorla's co-authors include Tatiana Galpérine, Élodie Blanchard, D. Neau, Jean‐Marie Ragnaud, Alexandre Karras, Daniel Vittecoq, Olivier Lambotte, Philippe Parola, Vincent Thibault and Gilles Pialoux and has published in prestigious journals such as Journal of Hepatology, Annals of the Rheumatic Diseases and QJM.

In The Last Decade

C. Cazorla

9 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Cazorla France 7 127 106 81 80 58 9 278
Luciano Attard Italy 12 114 0.9× 173 1.6× 128 1.6× 141 1.8× 42 0.7× 24 445
I. Gueït France 10 51 0.4× 111 1.0× 117 1.4× 26 0.3× 26 0.4× 22 340
Alberto Spanò Italy 13 92 0.7× 188 1.8× 110 1.4× 39 0.5× 29 0.5× 18 373
Valerio M. Novelli United States 10 234 1.8× 390 3.7× 33 0.4× 21 0.3× 42 0.7× 15 486
G. Sirera Spain 12 92 0.7× 328 3.1× 163 2.0× 181 2.3× 16 0.3× 28 571
Albanita V. Oliveira Brazil 11 14 0.1× 110 1.0× 92 1.1× 89 1.1× 47 0.8× 16 320
Şener Barut Türkiye 10 110 0.9× 123 1.2× 109 1.3× 59 0.7× 6 0.1× 38 303
E J Minton United Kingdom 7 146 1.1× 318 3.0× 26 0.3× 14 0.2× 39 0.7× 9 403
N. Scheiermann Germany 12 143 1.1× 228 2.2× 80 1.0× 33 0.4× 5 0.1× 47 404
Raffaella Marocco Italy 11 93 0.7× 162 1.5× 173 2.1× 11 0.1× 15 0.3× 30 385

Countries citing papers authored by C. Cazorla

Since Specialization
Citations

This map shows the geographic impact of C. Cazorla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Cazorla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Cazorla more than expected).

Fields of papers citing papers by C. Cazorla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Cazorla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Cazorla. The network helps show where C. Cazorla may publish in the future.

Co-authorship network of co-authors of C. Cazorla

This figure shows the co-authorship network connecting the top 25 collaborators of C. Cazorla. A scholar is included among the top collaborators of C. Cazorla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Cazorla. C. Cazorla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Saadoun, David, Vincent Thibault, Gilles Pialoux, et al.. (2015). P0813 : All oral therapy (Sofosbuvir–Ribavirin) combination in severe HCV-mixed cryoglobulinemia vasculitis, the vascuvaldic study. Journal of Hepatology. 62. S640–S640. 4 indexed citations
2.
Saadoun, David, Matthieu Resche‐Rigon, Stanislas Pol, et al.. (2014). PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. Journal of Hepatology. 62(1). 24–30. 87 indexed citations
3.
Saadoun, David, Vincent Thibault, M. Longuet, et al.. (2013). Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24. Annals of the Rheumatic Diseases. 73(5). 831–837. 57 indexed citations
4.
Doudier, Barbara, et al.. (2010). Leptospirosis diagnosed by molecular DNA detection on skin biopsy. BMJ Case Reports. 2010. bcr0920092313–bcr0920092313. 1 indexed citations
5.
Million, Matthieu, C. Cazorla, Barbara Doudier, et al.. (2009). Molecular identification ofBorrelia crociduraein a patient returning from Senegal: Figure 1. BMJ Case Reports. 2009. bcr0620080298–bcr0620080298. 12 indexed citations
6.
Cazorla, C., Cristina Socolovschi, Mogens Jensenius, & Philippe Parola. (2008). Tick-borne Diseases: Tick-borne Spotted Fever Rickettsioses in Africa. Infectious Disease Clinics of North America. 22(3). 531–544. 30 indexed citations
7.
Galpérine, Tatiana, et al.. (2007). Streptococcus canis infections in humans: Retrospective study of 54 patients. Journal of Infection. 55(1). 23–26. 65 indexed citations
8.
Ranque, Stéphane, B. Marchou, Denis Malvy, et al.. (2005). Treatment of imported malaria in adults: a multicentre study in France. QJM. 98(10). 737–743. 9 indexed citations
9.
Dupon, M., Bernard Masquelier, C. Cazorla, et al.. (1997). Acquired immunodeficiency syndrome-associated Kaposi's sarcoma and human herpesvirus 8 DNA detection in serial peripheral blood mononuclear cell samples. Research in Virology. 148(6). 417–425. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026